课题基金 / 基金详情

Functional analysis of cyclin D1 alternative transcript b

Functional analysis of cyclin D1 alternative transcript b
cyclin D1替代转录物b的功能分析
批准号:
10670980
负责人:
HOSOKAWA Yoshitaka
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

HOSOKAWA Yoshitaka的其他基金

相似基金

相关文献

中文摘要
翻译
细胞周期蛋白D1/PRAD 1癌基因是细胞周期G1期进展的关键调节因子,已被鉴定为在具有t(11;14)(q13;q32)易位的B细胞恶性肿瘤中长期寻找的BCL-1癌基因。最近,我们发现了一种新的选择性剪接的细胞周期蛋白D1转录本,称为转录本[B]。在几种人非淋巴癌细胞系中,变体转录本[B]的水平低于最初报道的细胞周期蛋白D1转录本(称为转录本[a])的水平,但尚未确定转录本[B]产物的内源性细胞表达。北方印迹分析和逆转录-聚合酶链反应(RT-PCR)分析显示,转录本[B] mRNA在具有t(11;14)(q13;q32)易位的B淋巴细胞系中表达良好,而在其他细胞中表达水平低得多或检测不到。使用人细胞周期蛋白D1特异性单克隆抗体的Western印迹分析,其可以识别和区分转录本[a]和[B]的产物,强烈表明转录本[B]蛋白确实在这些B细胞系中表达。本研究首次鉴定了细胞周期蛋白D1转录本[B]蛋白的内源性细胞表达,并强烈表明这种细胞周期蛋白D1的替代形式可能在伴有t(11;14)(q13;q32)易位的B淋巴恶性肿瘤的分子发病机制中发挥重要作用。转录本[B]的生物学功能及其在细胞周期调控中的作用有待进一步研究。
英文摘要
The cyclin D1/PRAD1 oncogene, a key regulator of the G1 phase progression of the cell cycle has been identified as the long-sought BCL-1 oncogene in B-cell malignancies with t(11;14)(q13;q32) translocation. Recently, a novel alternative spliced cyclin D1 transcript, called transcript [b], has been identified by ourselves. The level of the variant transcript [b] was lower than that of the originally reported cyclin D1 transcript, called transcript [a], in several human non-lymphoid cancer cell lines but the endogenous cellular expression of transcript [b] products has not yet been determined. Northern blot analysis and reverse transcription-polymerase chain reaction (RT-PCR) analysis revealed that the transcript [b] mRNAs are well expressed in B-lymphoid cell lines with t(11;14)(q13;q32) translocation and at much lower or undetectable levels in other cells. Western blot analysis using a human cyclin D1-specific monoclonal antibody, which can recognize and distinguish the products of transcripts [a] and [b], strongly suggested that the transcript [b] protein is indeed expressed in these B-cell lines. The present study provides the first identification of the endogenous cellular expression of the cyclin D1 transcript [b] protein and strongly suggests that this alternative form of cyclin D1 may play a significant role in the molecular pathogenesis of B-lymphoid malignancies with t(11;14)(q13;q32) translocation. Further studies are warranted to study the biological function of transcript [b] and its role in cell cycle control.
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
Hosokawa, Y. et al.: "Cylin D1/PRAD1/BCL-1 alternative transcript[b]protein product in B-lymphoid malignancies with t(11 ; 14)(q13 ; q32) translocation"International Journal of Cancer. 81. 616-619 (1999)
Hosokawa, Y. 等人:“具有 t(11; 14)(q13; q32) 易位的 B 淋巴恶性肿瘤中的 Cylin D1/PRAD1/BCL-1 替代转录物 [b] 蛋白产物”国际癌症杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hosokawa Y, Joh T, Maeda Y, Arnold A, and Seto M.: "Cyclin D1/PRAD1/BCL-1 alternative transcript [b] protein product in B-lymphoid malignancies with t(11;14)(q13;q32) translocation."Int. J. Cancer.. 81. 616-619 (1999)
Hosokawa Y、Joh T、Maeda Y、Arnold A 和 Seto M.:“具有 t(11;14)(q13;q32) 的 B 淋巴恶性肿瘤中的细胞周期蛋白 D1/PRAD1/BCL-1 替代转录物 [b] 蛋白产物
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Joh, T. et al.: "Establishment of an inducible expression system of chimenric MLL-LTG9 protein and inhibition of Hox α7, Hox b7 and Hox c9 expression by MLL-LTG9"Oncogene. 18. 1125-1130 (1999)
Joh,T.等人:“嵌合MLL-LTG9蛋白诱导表达系统的建立以及MLL-LTG9对Hox α7、Hox b7和Hox c9表达的抑制”Oncogene.18.1125-1130(1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Joh, T.et al.: "Establishment of an inducible expression system of chimeric MLL-LTG9 protein and inhibition of Hox a7, Hox b7 and Hox c9 expression by MLL-LTG9 in 32Dcl3 cells." Oncogene,. 18. 1125-1130 (1999)
Joh, T. 等人:“建立了嵌合 MLL-LTG9 蛋白的诱导表达系统,并在 32Dcl3 细胞中通过 MLL-LTG9 抑制 Hox a7、Hox b7 和 Hox c9 的表达。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
27
    Basic study of the bioactive substances of a skin of citrus fruits for periodontal disease treatment
    • 批准号:
      19K10151
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2019
    • 负责人:
      HOSOKAWA Yoshitaka
    • 依托单位:
    Analysis of leukocyte infiltration mechanism to participate in inflammatory bone resorption in periodontal lesion
    • 批准号:
      16K11834
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2016
    • 负责人:
      HOSOKAWA Yoshitaka
    • 依托单位:
    Analysis of Th17 cells migration and activation in periodontally diseased tissues
    • 批准号:
      25463219
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2013
    • 负责人:
      HOSOKAWA Yoshitaka
    • 依托单位:
    Analysis of Th17 cells migration inperiodontally diseased tissues.
    • 批准号:
      23792479
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.66万
    • 财政年份:
      2011
    • 负责人:
      HOSOKAWA Yoshitaka
    • 依托单位:
    海外基金